Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
They are the leaders in this niche, which has grown steadily over the past decade. Even so, Abbott Laboratories and Dexcom have underperformed broader equities in the past five years. However, given the massive opportunities available in the CGM market, they could bounce back and deliver much better returns from here on out. Which one is likely to outperform the other? Let's find out. Image source: Getty Images. Will AI create the world's first trillionaire? Our team just released a report on a little-known company, called an "Indispensable Monopoly," providing the critical technology Nvidia and Intel both need. Continue » Which one is the CGM leader? Abbott Laboratories stated several years ago that only 1% of the world's diabetics use CGM. That statistic highlights the massive opportunity ahead. Even if adoption has grown since then, the CGM market likely hasn't peaked yet. Abbott's CGM business features its famous FreeStyle Libre franchise, as well as the Libre Rio and th
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Why I Can't Stop Buying AbbVie Stock [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) had its price target lowered by Barclays PLC from $144.00 to $143.00. They now have an "overweight" rating on the stock.MarketBeat
- Has the Abbott Laboratories Sell-Off Finally Created an Entry Point? [Yahoo! Finance]Yahoo! Finance
- Abbott Stock Crash: Rebound Could Be Coming Fast [Yahoo! Finance]Yahoo! Finance
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/17/26 - Form 8-K
- 4/16/26 - Form 8-K
- 4/2/26 - Form 4
- ABT's page on the SEC website